Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
Titel:
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
Auteur:
Ketterer, N. Coiffier, B. Thieblemont, C. Fermé, C. Brière, J. Casasnovas, O. Bologna, S. Christian, B. Connerotte, T. Récher, C. Bordessoule, D. Fruchart, C. Delarue, R. Bonnet, C. Morschhauser, F. Anglaret, B. Soussain, C. Fabiani, B. Tilly, H. Haioun, C.